FDA Approves Alcon’s AcrySof(R) IQ ReSTOR(R) +3.0 D Intraocular Lens in the US. The product is already sold in Europe.
New Lens Corrects for Cataracts with Presbyopia
Related posts:
- Accommodative lens results considered ‘disappointing’ – IOL shifts forward but offers less than 0.5 D of pseudophakic accommodation – Modern Medicine
- Feds Warn Of Counterfeit Diabetes Tests
- Novartis Still On Track to Buy Majority In Alcon
- (More Unbridled Capitalism As) Patients Battle For Drugs In The UK
- Alcon second-quarter profit rises 26 pct
